Increasing concerns about an economic recession have kept the stock market under pressure. With Goldman Sachs expecting that the stock market is yet to hit bottom, market volatility seems evident. So,...
Reata (RETA) reports a wider-than-expected loss in the second quarter of 2022, while revenues miss estimates. Stock falls after updates on pipeline programs.
Health care is one of the better-performing sectors in 2022, with medical gear makers Medtronic and Intuitive Surgical outpacing the broader industry recently.
Investing in biotech stocks carries both risk and reward. This article highlights two biotech companies that may appeal to specific investing styles
When the market is falling, this trio keeps rising.
Income investors have a lot to like about these stocks.
Ironwood (IRWD) miss earnings and revenue estimates in the second quarter. Stock declines.
It won't be able to rely on Humira for growth for much longer.
AbbVie (ABBV) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
The health care sector is participating in the S&P's nascent rally, but pharmaceuticals AbbVie, Merck and Pfizer are holding up well relative to the market.
